A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 22 Nov 2018
At a glance
- Drugs GSK 2321138A (Primary) ; V 114 (Primary)
- Indications Pneumococcal infections
- Focus Adverse reactions; Pharmacodynamics; Registrational
- Acronyms PNEU-FLU
- Sponsors Merck Sharp & Dohme
- 11 Nov 2018 Status changed from recruiting to active, no longer recruiting.
- 26 Sep 2018 Status changed from not yet recruiting to recruiting.
- 22 Aug 2018 Planned initiation date changed from 3 Sep 2018 to 17 Sep 2018.